
RSV Awareness
Respiratory syncytial virus, or RSV, is a highly contagious seasonal virus that usually runs from October to April and affects most children by the time they are two years old. It is the leading cause of hospitalization for all infants under age one. Infants younger than one are 16 times more likely to be hospitalized for RSV than for the flu, and RSV accounts for 500,000 emergency room visits in young children each year.
Some infants experience only mild cold-like symptoms, but for others, RSV can cause bronchiolitis, pneumonia and respiratory distress, which can lead to hospitalization and mechanical ventilation. Some babies do not survive, while others survive with chronic respiratory issues that follow them into adulthood.
Join the National Coalition for Infant Health in raising awareness about RSV by sharing your own story and learning more in the educational materials below. Share them on social media using the hashtags #RSVAwareness and #RallyAgainstRSV.
Papers
Papers
RSV, or respiratory syncytial virus, is a common, highly contagious seasonal virus that affects 97% of children by the age of 2. Yet despite RSV being common among young children, most parents know little about it.
Vaccines and preventive monoclonal antibodies are two different types of immunization. While they function differently, they both serve the same purpose: protecting people from serious illnesses and diseases.
Respiratory syncytial virus places a heavy burden on infants, young children, their families and the health care system. Also known as RSV, this virus can impact children and families for months, years or even their entire lives.
And it doesn’t discriminate.
Videos
Videos
Watch Karen Crowley, DNP, Jeffereson Jones, MD, MPH, and Bob Hopkins, MD, give an overview of RSV, new options to prevent it and CDC guidance for their use, and resources for providers and patients/caregivers.
Watch L.J. Tan, MS, PhD, & Maria Woosley, DNP, APRN CPNP-AC discuss the different types of immunizations currently available, as well as those under review by FDA, policies impacting access to RSV immunizations and the real-world impact of RSV on infants, children and families.
To boost public health and maximize disease prevention, all immunizations should be treated the same.
A survey of 340 parents whose child caught RSV reveals the devastating burdens that families may experience when their child becomes ill. To manage the indirect impacts of RSV, policymakers must support innovation and ensure timely and equitable access to care and preventive interventions.
Emily's daughter Presley caught RSV and passed away in November 2021. Now, Emily advocates and raises awareness about RSV.
This survey briefing discusses the indirect impact and burden of RSV on babies, young children, their families and the health care providers who treat young RSV patients. Two surveys were conducted, one of parents who had at least one child contract RSV, and one of pediatric health care providers who treat babies and young children with RSV.
Much of the public is unaware of the severity of RSV. Patricia Whitley-Williams, MD, immediate past president of NFID and chief of Allergy, Immunology and Infectious Diseases at Rutgers Robert Wood Johnson Medical School, discusses health disparities that impact babies and young children with RSV.
While RSV can lead to severe symptoms for babies and young children, the virus can also result in heavy financial and emotional burdens for families.
Respiratory syncytial virus, also known as RSV, is a seasonal virus that affects nearly all infants and children before they are two years old.
General pediatrician Lynn Smitherman, MD, explains how the burden of RSV weighs heavily on babies, children and their families.
Melanie and Dan's daughter Reagan was hospitalized for 10 days after she was diagnosed with RSV. Despite doing everything they could to protect their children from the virus, a few years later both of their twin sons were also hospitalized with RSV.
Neonatologist Vincent Smith, MD, explains why RSV can be dangerous for infants and young children.
When Iowa Representative Megan Jones' son Archie was diagnosed with RSV, he spent 5 days in the hospital. Now, she works to raise awareness about the potentially deadly disease.
Infants need health care tailored to their age, weight and medical condition. But that's not always what they receive.
Preventive treatment can protect vulnerable preemies from deadly respiratory syncytial virus. But national data shows that insurance companies are denying access for the babies who need it.
The National Coalition for Infant Health summarizes results of its recent survey on RSV, which demonstrated that parents need more information about the potentially deadly disease.
Most young children encounter what’s known as Respiratory Syncytial Virus, or RSV, before age two. It’s a common seasonal virus with flu-like symptoms. But as this video from the National Coalition for Infant Health explains, premature infants whose health plans don’t cover preventive RSV treatment may suffer – and unnecessarily so.
In the early stages of RSV disease, the infant in the video struggles to breathe. Notice how his breastbone sinks inward when he breathes- this is retractions, and it means the baby is using all his strength to keep breathing.
Infographics
Infographics
Social Graphics
Social Graphics
Blogs & Press Releases
Blogs & Press Releases
The Food and Drug Administration will give priority review to a first-of-its-kind maternal vaccine against respiratory syncytial virus via the breakthrough therapy program.
It’s been called the “tripledemic” – the flu, COVID-19 and RSV colliding in a dangerous viral storm. And now new data suggest that RSV, or respiratory syncytial virus, may pose an even greater burden than some realized.
Health officials, the media, even the president, continue to urge Americans to protect themselves by getting vaccinated and boosted against COVID-19. I hope they will take the same dedicated approach if protection from RSV is one day a reality for all babies and young children.
After my infant son had open-heart surgery, I thought we’d been through the worst experience of our lives. Then he got RSV.
Including new monoclonal antibodies – vaccine-like interventions – in the Vaccines for Children program will reduce the burden of RSV and ensure access for all infants
Share Your Story